This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Plasma-Lyte 148 (pH 7.4)

Read time: 1 mins
Marketing start date: 08 Apr 2025
...
 

Summary of product characteristics


Effective Time

20241108

Version

1

Spl Product Data Elements

Plasma-Lyte 148 (pH 7.4) Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride, Magnesium Chloride SODIUM CHLORIDE SODIUM CATION CHLORIDE ION SODIUM GLUCONATE GLUCONIC ACID SODIUM CATION SODIUM ACETATE ACETATE ION SODIUM CATION POTASSIUM CHLORIDE POTASSIUM CATION CHLORIDE ION MAGNESIUM CHLORIDE MAGNESIUM CATION CHLORIDE ION WATER SODIUM HYDROXIDE

Brand Name

Plasma-Lyte 148 (pH 7.4)

Generic Name

Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride, Magnesium Chloride

Product Ndc

0338-9593

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL Container Label Baxter Viaflo GCCE0324 1000 mL 100 200 300 400 500 600 700 800 900 Plasma-Lyte 148 (pH 7.4) Solution for Infusion pH 6.5 – 8.0 Isotonic Osmolarity 295 m0sm/l (approx) Formula per 1000ml Sodium Chloride 5.26 g Potassium Chloride 0.37 g Magnesium Chloride hexahydrate 0.30 g Sodium Acetate trihydrate 3.68 g Sodium Gluconate 5.02 g Water for Injections Sodium Hydroxide mmol per 100 mL (approx) Sodium 140 Chloride 98 Potassium 5 Acetate 27 Magnesium 1.5 Gluconate 23 IV administration Read package leaflet before use Keep out of the sight and reach of children Do not remove from overwrap until ready for use Do not use unless solution is clear without visible particles and container undamaged Do not reconnect partially used bags Store below 30 o C POM 07 0 UN-35-03-560 1 Marketing Authorization Holder: Baxter Healthcare Ltd. Caxton Way Thetford Norfolk IP 24 3SE United Kingdom Manufacturer: Bieffe Medital S.A. Ctra de Biescas-Senegüé 22666 Sabiñánigo (Huesca) Spain LOT EXP PlasmaLyte 1000ml Representative Container Label.jpg

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.